iodine has been researched along with Glioma in 9 studies
Iodine: A nonmetallic element of the halogen group that is represented by the atomic symbol I, atomic number 53, and atomic weight of 126.90. It is a nutritionally essential element, especially important in thyroid hormone synthesis. In solution, it has anti-infective properties and is used topically.
diiodine : Molecule comprising two covalently bonded iodine atoms with overall zero charge..
Glioma: Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Therapy monitoring of glioma after stereotactic iodine-125 brachytherapy (SBT) remains challenging because posttherapeutic changes in magnetic resonance imaging can mimic tumor progression." | 7.79 | [18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma. ( Bartenstein, P; Belka, C; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Schwarz, SB; Suchorska, B, 2013) |
| "To augment the therapeutic efficacy of BNCT, we used transferrin-conjugated polyethylene glycol (PEG) (TF-PEG) liposome encapsulating sodium borocaptate and Iomeprol, an iodine contrast agent, with intratumoral convection-enhanced delivery (CED) in a rat glioma tumor model." | 7.77 | Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. ( Doi, A; Hiramatsu, R; Ikeda, N; Kasaoka, S; Kawabata, S; Kuroiwa, T; Maruyama, K; Miyata, S; Miyatake, S; Yamashita, T, 2011) |
| "Gliomas and other brain tumors have evaded durable therapies, ultimately causing about 20% of all cancer deaths." | 5.51 | Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy. ( Hainfeld, JF; Panchal, R; Ridwan, SM; Slatkin, DN; Smilowitz, HM; Stanishevskiy, Y, 2019) |
| "Therapy monitoring of glioma after stereotactic iodine-125 brachytherapy (SBT) remains challenging because posttherapeutic changes in magnetic resonance imaging can mimic tumor progression." | 3.79 | [18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma. ( Bartenstein, P; Belka, C; Eigenbrod, S; Graute, V; Jansen, NL; Kreth, FW; la Fougère, C; Lutz, J; Schwarz, SB; Suchorska, B, 2013) |
| "To augment the therapeutic efficacy of BNCT, we used transferrin-conjugated polyethylene glycol (PEG) (TF-PEG) liposome encapsulating sodium borocaptate and Iomeprol, an iodine contrast agent, with intratumoral convection-enhanced delivery (CED) in a rat glioma tumor model." | 3.77 | Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy. ( Doi, A; Hiramatsu, R; Ikeda, N; Kasaoka, S; Kawabata, S; Kuroiwa, T; Maruyama, K; Miyata, S; Miyatake, S; Yamashita, T, 2011) |
| " Two complimentary SSR approaches have been successfully developed in the past 5 years in our team, and may be promising in high-grade glioma management: iodine-enhanced SSR, with an iodinated contrast agent; and Pt-enhanced SSR; a concomitant radio-chemotherapy treatment with locoregional injection of platinated chemotherapy drugs." | 3.74 | Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment. ( Adam, JF; Balosso, J; Biston, MC; Boudou, C; Charvet, AM; Elleaume, H; Estève, F; Rousseau, J, 2008) |
| "Comparison of different contrast dosages in adult patients with malignant gliomas studied by computed tomography indicates that 28-42 g of iodine is required for clinically diagnostic results." | 3.66 | Optimal contrast dosage in cranial computed tomography. ( Enzmann, DR; Newton, TH; Norman, D, 1978) |
| "Gliomas and other brain tumors have evaded durable therapies, ultimately causing about 20% of all cancer deaths." | 1.51 | Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy. ( Hainfeld, JF; Panchal, R; Ridwan, SM; Slatkin, DN; Smilowitz, HM; Stanishevskiy, Y, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 3 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hainfeld, JF | 1 |
| Ridwan, SM | 1 |
| Stanishevskiy, Y | 1 |
| Panchal, R | 1 |
| Slatkin, DN | 1 |
| Smilowitz, HM | 1 |
| Jansen, NL | 1 |
| Suchorska, B | 1 |
| Schwarz, SB | 1 |
| Eigenbrod, S | 1 |
| Lutz, J | 1 |
| Graute, V | 1 |
| Bartenstein, P | 1 |
| Belka, C | 1 |
| Kreth, FW | 1 |
| la Fougère, C | 1 |
| Miyata, S | 1 |
| Kawabata, S | 1 |
| Hiramatsu, R | 1 |
| Doi, A | 1 |
| Ikeda, N | 1 |
| Yamashita, T | 1 |
| Kuroiwa, T | 1 |
| Kasaoka, S | 1 |
| Maruyama, K | 1 |
| Miyatake, S | 1 |
| FEINDEL, W | 1 |
| YAMAMOTO, YL | 1 |
| MCRAE, DL | 1 |
| ZANELLI, J | 1 |
| Adam, JF | 2 |
| Elleaume, H | 3 |
| Joubert, A | 1 |
| Biston, MC | 2 |
| Charvet, AM | 3 |
| Balosso, J | 2 |
| Le Bas, JF | 2 |
| Estève, F | 3 |
| Rousseau, J | 1 |
| Boudou, C | 1 |
| Le Duc, G | 1 |
| Bertrand, B | 1 |
| Corde, S | 1 |
| Farion, R | 1 |
| Lefaix, JL | 1 |
| Leplat, JJ | 1 |
| Berkvens, P | 1 |
| Berruyer, G | 1 |
| Brochard, T | 1 |
| Dabin, Y | 1 |
| Draperi, A | 1 |
| Fiedler, S | 1 |
| Nemoz, C | 1 |
| Perez, M | 1 |
| Renier, M | 1 |
| Suortti, P | 1 |
| Thomlinson, W | 1 |
| Norman, D | 2 |
| Enzmann, DR | 1 |
| Newton, TH | 2 |
| Stevens, EA | 1 |
| Wing, SD | 1 |
| Levin, V | 1 |
9 other studies available for iodine and Glioma
| Article | Year |
|---|---|
Iodine nanoparticles enhance radiotherapy of intracerebral human glioma in mice and increase efficacy of chemotherapy.
Topics: Animals; Antineoplastic Agents; Brain Neoplasms; Cell Line, Tumor; Chemoradiotherapy; Doxorubicin; F | 2019 |
[18F]fluoroethyltyrosine-positron emission tomography-based therapy monitoring after stereotactic iodine-125 brachytherapy in patients with recurrent high-grade glioma.
Topics: Brachytherapy; Disease-Free Survival; Glioma; Humans; Iodine; Magnetic Resonance Imaging; Positron-E | 2013 |
Computed tomography imaging of transferrin targeting liposomes encapsulating both boron and iodine contrast agents by convection-enhanced delivery to F98 rat glioma for boron neutron capture therapy.
Topics: Animals; Borohydrides; Boron Neutron Capture Therapy; Brain Neoplasms; Contrast Media; Drug Delivery | 2011 |
CONTOUR BRAIN SCANNING WITH IODINE AND MERCURY COMPOUNDS FOR DETECTION OF INTRACRANIAL TUMORS.
Topics: Arsenicals; Bismuth; Brain; Brain Neoplasms; Chlormerodrin; Diuretics; Glioma; Hemangiosarcoma; Iodi | 1964 |
Synchrotron radiation therapy of malignant brain glioma loaded with an iodinated contrast agent: first trial on rats bearing F98 gliomas.
Topics: Algorithms; Animals; Brain Neoplasms; Cell Line, Tumor; Contrast Media; Glioma; Iodine; Male; Radiot | 2003 |
Heavy element enhanced synchrotron stereotactic radiotherapy as a promising brain tumour treatment.
Topics: Animals; Biophysical Phenomena; Biophysics; Brain Neoplasms; Contrast Media; Glioma; Humans; Idoxuri | 2008 |
In vivo K-edge imaging with synchrotron radiation.
Topics: Animals; Brain Neoplasms; Contrast Media; Coronary Angiography; Europe; Gadolinium; Glioma; Humans; | 2000 |
Optimal contrast dosage in cranial computed tomography.
Topics: Brain Neoplasms; Contrast Media; Glioma; Humans; Injections, Intravenous; Iodine; Tomography, X-Ray | 1978 |
Quantitative aspects of contrast enhancement in cranial computed tomography.
Topics: Blood-Brain Barrier; Brain Neoplasms; Contrast Media; Glioma; Humans; Injections, Intravenous; Iodin | 1978 |